GENOMAR GENETICS AS

Keywords

researchdevelopment workbiotechnologygenomicspharmageneticsgene samplesdna sequencingdna synthesisdna deepeninggenetic engineeringproteinsmoleculespeptide sequencinglipidglycotechniqueproteomicshormonesgrowth factorscell receptorspheromonescell culturetissue culturecrossingcell fusionvaccineimmunostimulatorsembryo manipulationprocess biotechnologybioreactorsfermentationbioprocessingbiorecoverybiodesulfurizationbiological pulp productionbiofiltrationbiological regenerationsubcellular organismsgene therapyvirusesvectors

Organization

Chairman of the board: OM
Odd Magne Rødseth1960
Years since formation: 10 years; since Sep 9, 2015
Type: Limited company
VAT registered: Yes
Number of employees: 0

Ownership

Number of shares and share classes: 1,500; 1 share class
Total number of shareholders: 1; company
Belongs to group of

Financials

Total operating income 2023: 6,997,886; NOK
Annual total result 2023: -4,573,035; NOK
Total equity 2023: 143,989,326; NOK

Last update: Nov 28, 2024

Management

Board

Name	Role	Shares
OM Odd Magne Rødseth 1960	Contact Person, Chairman	-

Others

Name	Role	Shares
D DELOITTE AS	Auditor	-
A AZETS INSIGHT AS	Accountant	-

Last update: Apr 13, 2023

Ownership

Company shareholders

Name	Share class	Number of shares	Share
B BLUE FUTURE HOLDING AS	Ordinary shares	1,500	100 %

Last update: May 24, 2024

Group structure

BLUE FUTURE HOLDING AS
Total operating income 2023: NOK 8,295,593
Operating profit 2023: NOK -6,697,188
Employees: 0

Financials

in NOK

Summary

Year	2022	2021
Total operating income	6,997,886	6,786,384
Annual Total Result	-4,573,035	-3,737,789
Total assets	204,006,574	162,790,836
Total liabilities	60,017,248	19,458,707
Total equity	143,989,326	143,332,130

P&L

Year	2022	2021
Total operating income	6,997,886	6,786,384
Total operating costs	36,227,430	28,468,395
Operating result	-29,229,543	-21,682,011
Financial income/costs	23,122,362	16,482,458
Profit before tax	-6,107,182	-5,199,553
Total tax & extraordinary income/cost	-1,534,147	-1,461,764
Annual Total Result	-4,573,035	-3,737,789

Balance overview

Year	2022	2021
Total fixed assets	175,288,176	136,653,806
Total current assets	28,718,398	26,137,030
Total assets	204,006,574	162,790,836
Short term debt	4,975,379	5,661,739
Long term debt	55,041,870	13,796,968
Total liabilities	60,017,248	19,458,707
Contributed capital	206,876,735	201,646,504
Retained earnings	-62,887,409	-58,314,374
Total equity	143,989,326	143,332,130
Total equity and liabilities	204,006,574	162,790,837

GENOMAR GENETICS AS915 894 658